Myeloproliferative neoplasms: open trials in Denmark

• NCT04176198

  A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

  Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.

  Region Midtjylland, Aarhus N

  Registry updated 2026-10-02

• 2024-511309-47-00

  A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor-naïve myelofibrosis and moderate thrombocytopenia.

  Trial Treatment · Phase 2 · Karyopharm Therapeutics Inc.

  Aarhus Universitetshospital, Aarhus N

  Registry updated 2026-09-25

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-07-06

• NCT05980806

  A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

  Trial Treatment · Phase 2 · Karyopharm Therapeutics Inc

  Aarhus Universitetshospital, Aarhus N

  Registry updated 2026-02-12

All Myeloproliferative neoplasms trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error